loading
Precedente Chiudi:
$662.62
Aprire:
$658
Volume 24 ore:
1.68M
Relative Volume:
1.95
Capitalizzazione di mercato:
$71.99B
Reddito:
$14.20B
Utile/perdita netta:
$4.41B
Rapporto P/E:
17.20
EPS:
38.28
Flusso di cassa netto:
$3.54B
1 W Prestazione:
-1.26%
1M Prestazione:
-5.98%
6M Prestazione:
-42.49%
1 anno Prestazione:
-31.98%
Intervallo 1D:
Value
$651.06
$661.00
Intervallo di 1 settimana:
Value
$651.06
$679.83
Portata 52W:
Value
$642.00
$1,211.20

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
Nome
Regeneron Pharmaceuticals Inc
Name
Telefono
(914) 847-7000
Name
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
Dipendente
0
Name
Cinguettio
@regeneron
Name
Prossima data di guadagno
2025-02-04
Name
Ultimi documenti SEC
Name
REGN's Discussions on Twitter

Confronta REGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
658.48 71.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.20 129.22B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
ARGX
Argen X Se Adr
615.02 37.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
283.34 36.68B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
251.98 27.10B 3.81B -644.79M -669.77M -6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-05 Aggiornamento Leerink Partners Market Perform → Outperform
2025-01-16 Downgrade UBS Buy → Neutral
2024-12-10 Ripresa BofA Securities Underperform
2024-11-15 Iniziato Wolfe Research Outperform
2024-11-14 Iniziato Citigroup Neutral
2024-09-24 Downgrade Leerink Partners Outperform → Market Perform
2024-03-12 Iniziato Bernstein Outperform
2024-01-12 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-11-03 Aggiornamento Raymond James Mkt Perform → Outperform
2023-08-21 Aggiornamento Canaccord Genuity Hold → Buy
2023-08-21 Reiterato Oppenheimer Perform
2023-06-28 Downgrade Canaccord Genuity Buy → Hold
2023-03-27 Aggiornamento SVB Securities Market Perform → Outperform
2023-03-24 Aggiornamento Jefferies Hold → Buy
2023-03-23 Aggiornamento Raymond James Underperform → Mkt Perform
2023-01-30 Aggiornamento Cowen Market Perform → Outperform
2023-01-20 Aggiornamento JP Morgan Neutral → Overweight
2022-10-26 Downgrade Raymond James Mkt Perform → Underperform
2022-10-17 Downgrade Evercore ISI Outperform → In-line
2022-09-09 Aggiornamento Jefferies Underperform → Hold
2022-09-09 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-07-25 Downgrade SVB Leerink Outperform → Mkt Perform
2022-07-13 Iniziato Cantor Fitzgerald Neutral
2022-06-06 Iniziato Jefferies Underperform
2022-05-23 Iniziato SVB Leerink Outperform
2022-01-05 Downgrade BofA Securities Neutral → Underperform
2022-01-03 Aggiornamento Bernstein Mkt Perform → Outperform
2021-12-15 Downgrade Bernstein Outperform → Mkt Perform
2021-12-09 Ripresa Wells Fargo Overweight
2021-12-07 Ripresa Cowen Market Perform
2021-12-06 Iniziato Goldman Buy
2021-11-19 Ripresa BMO Capital Markets Outperform
2021-11-05 Downgrade The Benchmark Company Buy → Hold
2021-06-29 Iniziato H.C. Wainwright Buy
2021-01-25 Aggiornamento BMO Capital Markets Market Perform → Outperform
2021-01-13 Aggiornamento The Benchmark Company Hold → Buy
2021-01-08 Aggiornamento Citigroup Neutral → Buy
2020-10-05 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2020-08-20 Downgrade The Benchmark Company Buy → Hold
2020-07-09 Aggiornamento SunTrust Hold → Buy
2020-05-26 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-04-28 Downgrade Citigroup Buy → Neutral
2020-04-17 Aggiornamento The Benchmark Company Hold → Buy
2020-04-08 Iniziato The Benchmark Company Hold
2020-03-31 Iniziato Wolfe Research Peer Perform
2020-02-27 Iniziato Barclays Overweight
2020-02-26 Aggiornamento Canaccord Genuity Hold → Buy
2020-02-26 Downgrade Robert W. Baird Outperform → Neutral
2020-02-25 Aggiornamento Jefferies Hold → Buy
2020-02-11 Aggiornamento Argus Hold → Buy
2019-12-24 Iniziato Raymond James Mkt Perform
2019-12-16 Downgrade Evercore ISI Outperform → In-line
2019-12-13 Aggiornamento Credit Suisse Neutral → Outperform
2019-11-12 Iniziato SunTrust Hold
2019-11-07 Aggiornamento Citigroup Neutral → Buy
2019-10-17 Ripresa BofA/Merrill Neutral
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
Mostra tutto

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
06:46 AM

Forefront Wealth Management Inc. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:46 AM
pulisher
06:34 AM

American Century Companies Inc. Sells 30,949 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:34 AM
pulisher
06:27 AM

Virtu Financial LLC Has $3.06 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:27 AM
pulisher
06:13 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Summit Global Investments - MarketBeat

06:13 AM
pulisher
05:27 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Teacher Retirement System of Texas - MarketBeat

05:27 AM
pulisher
04:26 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

04:26 AM
pulisher
04:26 AM

Madison Investment Advisors LLC Takes $4.59 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

04:26 AM
pulisher
03:12 AM

Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Grows By 16.8% - MarketBeat

03:12 AM
pulisher
Mar 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Royal London Asset Management Ltd. - MarketBeat

Mar 22, 2025
pulisher
Mar 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Envestnet Portfolio Solutions Inc. - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

DCF Advisers LLC Has $6.34 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Advisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

iA Global Asset Management Inc. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Avantax Advisory Services Inc. - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Commonwealth Equity Services LLC Sells 967 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

11,358 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Generali Asset Management SPA SGR - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Nikko Asset Management Americas Inc. Sells 2,730 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards - PR Newswire

Mar 21, 2025
pulisher
Mar 21, 2025

First Week of November 21st Options Trading For Regeneron Pharmaceuticals (REGN) - Nasdaq

Mar 21, 2025
pulisher
Mar 21, 2025

Blueshift Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Vinva Investment Management Ltd Buys 1,182 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

3 Reasons to Sell REGN and 1 Stock to Buy Instead - Financial Content

Mar 21, 2025
pulisher
Mar 21, 2025

Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Increases By 16.8% - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Cibc World Markets Corp Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Age-Related Macular Degeneration Therapeutics Market - openPR

Mar 21, 2025
pulisher
Mar 20, 2025

Kazazian Asset Management LLC Invests $399,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Harvest Fund Management Co. Ltd Acquires 1,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Xponance Inc. Boosts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Thrivent Financial for Lutherans Has $89.18 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Corient Private Wealth LLC Sells 4,349 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 20, 2025

Intact Investment Management Inc. Acquires Shares of 500 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

To Register Unwavering Growth Of Age-related Vision - openPR

Mar 19, 2025
pulisher
Mar 19, 2025

Refractory Multiple Myeloma Treatment Market Size in 7MM - openPR

Mar 19, 2025
pulisher
Mar 19, 2025

Greykasell Wealth Strategies Inc. Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

Achmea Investment Management B.V. Reduces Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 18, 2025
pulisher
Mar 18, 2025

AGF Management Ltd. Purchases 942 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 18, 2025
pulisher
Mar 18, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Trading Down 1.8%Here's Why - MarketBeat

Mar 18, 2025
pulisher
Mar 18, 2025

Where are the Opportunities in (REGN) - Stock Traders Daily

Mar 18, 2025
pulisher
Mar 18, 2025

Price Over Earnings Overview: Regeneron Pharmaceuticals - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Regeneron Pharmaceuticals (REGN): Among the Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 18, 2025
pulisher
Mar 17, 2025

Bowen Hanes & Co. Inc. Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

PGGM Investments Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Jim Cramer Wants You to ‘Own’ Regeneron Pharmaceuticals (REGN) Shares - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

Regeneron Pharmaceuticals (NasdaqGS:REGN) Shares Dip 1% Despite Positive Dupixent Trial Results - Simply Wall St

Mar 17, 2025
pulisher
Mar 17, 2025

Diabetic Retinopathy Treatment Market Growth, Latest Insights - openPR

Mar 17, 2025
pulisher
Mar 17, 2025

Amgen’s Bufferless Eylea Biosimilar Again Knocks Back Regeneron’s Injunctive Bid - Citeline

Mar 17, 2025
pulisher
Mar 17, 2025

The Biotech Stocks Tackling the World’s Most Common Cancer - Value the Markets

Mar 17, 2025
pulisher
Mar 17, 2025

Natixis Advisors LLC Sells 7,064 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Swiss National Bank Sells 15,300 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Bronte Capital Management Pty Ltd. Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Mar 17, 2025

Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Regeneron Pharmaceuticals Inc Azioni (REGN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
McCourt Marion
EVP Commercial
Nov 01 '24
Option Exercise
381.40
1,000
381,400
13,931
McCourt Marion
EVP Commercial
Nov 01 '24
Sale
844.61
1,000
844,610
12,931
$615.02
price up icon 0.32%
$283.34
price up icon 11.75%
biotechnology ONC
$251.98
price down icon 4.04%
$95.38
price down icon 0.88%
$503.20
price down icon 1.37%
Capitalizzazione:     |  Volume (24 ore):